Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Ruedy currently holds 104,810 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Ruedy has been a net buyer of BJCT stock. They have purchased $18.4K and sold $0 worth of shares.
John Ruedy's most recent insider trade was on Jun 5, 2009, when they sold 19,000 shares at $0.00 per share.
John Ruedy serves as Executive at BIOJECT MEDICAL TECHNOLOGIES INC (BJCT). They have executed 8 insider transactions totaling $18.4K over their tenure at the company.
John Ruedy holds the position of Executive at BIOJECT MEDICAL TECHNOLOGIES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John Ruedy has shown a buying trading pattern, with $18.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John Ruedy was on Jun 15, 2006, when they purchased $18.4K worth of BJCT shares. This transaction involved 15,000 shares at $1.23 per share.
John Ruedy currently owns 104,810 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Ruedy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Ruedy has 8 Form 4 filings on record as an insider at BIOJECT MEDICAL TECHNOLOGIES INC.
Set alerts for John Ruedy and 40,000+ other insiders.